Biosimilars: considerations for an abbreviated pathway.

Leuk Lymphoma

US Food and Drug Administration, Office of Biotechnology Products, Silver Spring, MD 20993, USA.

Published: April 2009

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190902853151DOI Listing

Publication Analysis

Top Keywords

biosimilars considerations
4
considerations abbreviated
4
abbreviated pathway
4
biosimilars
1
abbreviated
1
pathway
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!